Clinical Trial Update: CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a CD70-directed CAR T-cell therapy for pediatric hematologic malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Lymphoma
• Myelodysplastic Syndrome

Drugs mentioned

• CD70-directed CAR T-cell therapy (CD70-targeted CAR T-cell therapy)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Hematologic Malignancy, ALL, Childhood | Phase 1 | Status: RECRUITING